Tevogen Bio Holdings Inc. Quarterly Liabilities and Equity in USD from Q3 2021 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Tevogen Bio Holdings Inc. quarterly Liabilities and Equity history and growth rate from Q3 2021 to Q4 2024.
  • Tevogen Bio Holdings Inc. Liabilities and Equity for the quarter ending December 31, 2024 was $3.46M, a 37.1% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $3.46M -$2.04M -37.1% Dec 31, 2024 10-K 2025-04-02
Q3 2024 $4.29M -$22.1M -83.8% Sep 30, 2024 10-Q 2024-11-19
Q2 2024 $3.31M -$23.1M -87.4% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $3.36M -$22.1M -86.8% Mar 31, 2024 10-Q 2024-05-28
Q4 2023 $5.51M -$352M -98.5% Dec 31, 2023 10-K 2025-04-02
Q3 2023 $26.4M -$328M -92.6% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $26.4M -$327M -92.5% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 $25.5M -$327M -92.8% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 $357M +$4.29M +1.22% Dec 31, 2022 10-K 2024-04-29
Q3 2022 $355M +$354M +212469% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $353M Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $353M Mar 31, 2022 10-Q 2022-05-17
Q4 2021 $353M Dec 31, 2021 10-K 2023-04-17
Q3 2021 $167K Sep 30, 2021 10-Q 2021-12-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.